BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 19375729)

  • 1. Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats.
    Canguven O; Lagoda G; Sezen SF; Burnett AL
    J Urol; 2009 Jun; 181(6):2816-22. PubMed ID: 19375729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated RhoA/Rho kinase impairs erectile function after cavernous nerve injury in rats.
    Gratzke C; Strong TD; Gebska MA; Champion HC; Stief CG; Burnett AL; Bivalacqua TJ
    J Urol; 2010 Nov; 184(5):2197-204. PubMed ID: 20851436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(Adenosine diphosphate-ribose) polymerase inhibition preserves erectile function in rats after cavernous nerve injury.
    Kendirci M; Zsengellér Z; Bivalacqua TJ; Gur S; Usta MF; Chen M; Szabó C; Hellstrom WJ
    J Urol; 2005 Nov; 174(5):2054-9. PubMed ID: 16217393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of annexin-A1 against irreversible damage to cavernous tissue after cavernous nerve injury in the rat.
    Facio FN; Burnett AL
    BJU Int; 2012 Nov; 110(9):1346-51. PubMed ID: 22520236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of erectile function by suppression of corporal apoptosis, fibrosis and corporal veno-occlusive dysfunction with rho-kinase inhibitors in a rat model of cavernous nerve injury.
    Cho MC; Park K; Kim SW; Paick JS
    J Urol; 2015 May; 193(5):1716-23. PubMed ID: 25444982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losartan improves erectile function through suppression of corporal apoptosis and oxidative stress in rats with cavernous nerve injury.
    Wang Y; Meng XH; Zhang QJ; Wang YM; Chen C; Wang YC; Zhou X; Ji CJ; Song NH
    Asian J Androl; 2019; 21(5):452-459. PubMed ID: 30880689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin promotes the recovery of erectile function following cavernous nerve injury.
    Allaf ME; Hoke A; Burnett AL
    J Urol; 2005 Nov; 174(5):2060-4. PubMed ID: 16217394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intracavernosal growth differentiation factor-5 therapy in a rat model of cavernosal nerve injury.
    Fandel TM; Bella AJ; Tantiwongse K; Garcia M; Nunes L; Thüroff JW; Tanagho EA; Pohl J; Lue TF
    BJU Int; 2006 Sep; 98(3):632-6. PubMed ID: 16796696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury.
    Burnett AL; Becker RE
    J Urol; 2004 Jan; 171(1):495-500. PubMed ID: 14665962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model of cavernous nerve injury-induced erectile dysfunction: functional and morphological characterization of the corpus cavernosum.
    Jin HR; Chung YG; Kim WJ; Zhang LW; Piao S; Tuvshintur B; Yin GN; Shin SH; Tumurbaatar M; Han JY; Ryu JK; Suh JK
    J Sex Med; 2010 Oct; 7(10):3351-64. PubMed ID: 20646178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracavernous growth differentiation factor-5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury.
    Fandel TM; Bella AJ; Lin G; Tantiwongse K; Lin CS; Pohl J; Lue TF
    J Sex Med; 2008 Aug; 5(8):1866-75. PubMed ID: 18564148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506 binding protein 12 is expressed in rat penile innervation and upregulated after cavernous nerve injury.
    Sezen SF; Blackshaw S; Steiner JP; Burnett AL
    Int J Impot Res; 2002 Dec; 14(6):506-12. PubMed ID: 12494287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve injury-related erectile dysfunction following nerve-sparing radical prostatectomy: a novel experimental dissection model.
    Yamashita S; Kato R; Kobayashi K; Hisasue S; Arai Y; Tsukamoto T
    Int J Urol; 2009 Nov; 16(11):905-11. PubMed ID: 19780868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Chinese herbal medicine mixture on a rat model of hypercholesterolemic erectile dysfunction.
    Bakircioglu ME; Hsu K; El-Sakka A; Sievert KD; Lin CS; Lue TF
    J Urol; 2000 Nov; 164(5):1798-801. PubMed ID: 11025772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle Improved Stem Cell Therapy for Erectile Dysfunction in a Rat Model of Cavernous Nerve Injury.
    Lin H; Dhanani N; Tseng H; Souza GR; Wang G; Cao Y; Ko TC; Jiang H; Wang R
    J Urol; 2016 Mar; 195(3):788-95. PubMed ID: 26519654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of transforming growth factor-beta1 in penile tissue from rats with bilateral cavernosal nerve ablation.
    Hu WL; Hu LQ; Li SW; Zheng XM; Tian BC
    BJU Int; 2004 Aug; 94(3):424-8. PubMed ID: 15291880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The additive erectile recovery effect of brain-derived neurotrophic factor combined with vascular endothelial growth factor in a rat model of neurogenic impotence.
    Chen KC; Minor TX; Rahman NU; Ho HC; Nunes L; Lue TF
    BJU Int; 2005 May; 95(7):1077-80. PubMed ID: 15839936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan attenuates ventilator-induced lung injury.
    Yao S; Feng D; Wu Q; Li K; Wang L
    J Surg Res; 2008 Mar; 145(1):25-32. PubMed ID: 17688881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of intracavernous delivery of adenovirus encoding Smad7 gene on erectile function in a mouse model of cavernous nerve injury.
    Song KM; Chung JS; Choi MJ; Jin HR; Yin GN; Kwon MH; Park JM; Kim WJ; Lee SJ; Kim SJ; Ryu JK; Suh JK
    J Sex Med; 2014 Jan; 11(1):51-63. PubMed ID: 24433558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of nerve growth factor in cavernous tissue and its effects on the treatment of rats with diabetic erectile dysfunction].
    Dai YT; Chen Y; Yao LS; Yang R; Sun ZY; Wen DG
    Zhonghua Nan Ke Xue; 2005 Oct; 11(10):748-51, 754. PubMed ID: 16281507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.